The AstraZeneca Saga

Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. 

By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?

Guest: 

Peter Aldhous, science reporter at Buzzfeed News

Host

Lizzie O’Leary

Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.

Hosted on Acast. See acast.com/privacy for more information.